Introduction Osteosarcoma is an extremely rare form of cancer that primarily affects children and adolescents.1 It is characterized by the development of bone tumors, and there is a high incidence in teenagers and a second peak in adults older than 65, which is often associated with chronic bone diseases such as Paget’s disease.2,3 The global […]
Introduction Nearly 300,000 women in the United States (US) will be diagnosed with breast cancer in 2022, with an estimated 43,250 deaths.1 Approximately 6% of newly diagnosed breast cancer patients are reported to be de novo metastatic (stage IV disease) at the time of diagnosis, among whom the 5-year survival rate was 29%.1 In addition, approximately […]
Practice patterns by type of operation In total, there were 18,216 appendiceal tumors in the study group, including 1,970 (11%) GCA, 6,219 (34%) mucinous adenocarcinoma, 5,603 (31%) NEN, and 4,424 (24%) non-mucinous adenocarcinoma tumors. A majority of all patients were treated with RHC (60%). Overall, RHC was most frequently performed in GCA (69%) and least […]
Thom Filicia discusses bone marrow donation and myelofibrosis. Courtesy of GSK. It’s been a decade since Thom Filicia, acclaimed interior designer and former co-star of “Queer Eye for the Straight Guy,” served as a bone marrow donor for his brother, Jules, who had received a diagnosis of myelofibrosis. “It was a disease I knew nothing […]
Halloween wasn’t the only event in October worth celebrating. In the October episode of Snap Recap, CancerNetwork® reviews key news items as decided on by our readers. This included articles on the effectiveness of reducing ctDNA tumor fractions with neoadjuvant chemotherapy in triple-negative breast cancer, the benefits of hypofractionated vs standard radiotherapy for breast cancer, […]
CURE and Incyte Corporation are proud to host the 2023 MPN Heroes recognition ceremony, an evening of gratitude and celebration of the heroes who have made a significant impact in the lives of patients with myeloproliferative neoplasms, or MPNs. CRANBURY, N.J., Nov. 16, 2023 (GLOBE NEWSWIRE) — CURE Media Group, the industry-leading multimedia platform devoted to providing […]
CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition program News Home Thursday, November 16, 2023 10:38 AM | GlobeNewswire via QuoteMedia CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition program CURE and Incyte Corporation are proud to host the 2023 MPN Heroes […]
Introduction Therapies targeting programmed death 1 (PD1) and its ligand (PD-L1), as well as CTL-associated protein 4 (CTLA-4), referred to ICI, exhibit remarkable survival benefits compared to conventional treatments.1–4 Over the decades, the application of ICI has demonstrated promising results in treating LUAD patients.5–7 Nevertheless, a primary worry revolves around the inadequate patient response rate […]
Abstract Although gastric endoscopic submucosal dissection (ESD) is widely used, the degree of difficulty varies greatly depending on the lesion. Since the multi-loop traction device (MLTD) has been suggested to shorten the procedure time in colorectal ESD, we examined the efficacy and safety of using the MLTD in gastric ESD. Thirty patients with gastric neoplasms […]
